03.07.12
The European Union is investing €6 million in an international research project evaluating the immune health effects of Wellmune WGP from Biothera, Eagan, MN, and several other functional food ingredients.
The FibeBiotics project is a consortium of four European universities, five research institutions and several private companies that will study the effect of food fibers on the human immune system. Wageningen UR Food & Biobased Research, The Netherlands, is coordinating the 4.5-year project.
Wellmune WGP is a gluco polysaccharide that is clinically proven to safely prime key immune cells that help keep the body healthy. Derived from a proprietary strain of yeast, Wellmune WGP mobilizes neutrophils, which are the largest population of immune cells in the body and part of the body’s first line of defense.
“We are pleased that Wellmune WGP is part of this important scientific research project,” said Rich Mueller, Biothera president and CEO. “It will be complementary to our internal research program that is designed to expand understanding of our unique technology and its global immune health benefits.”
According to a FibeBiotics statement: “Research indicated that some specific polysaccharides, for example those from the cell wall of yeast or those that are present in various plant products, can activate the immune system starting from the intestine, even when no intruders are present. Various polysaccharides have been shown to activate macrophages, which can ‘digest’ pathogens and unwanted cells. An activated, warned or primed first layer of defence can help to improve the overall resistance of humans.”
The FibeBiotics project is a consortium of four European universities, five research institutions and several private companies that will study the effect of food fibers on the human immune system. Wageningen UR Food & Biobased Research, The Netherlands, is coordinating the 4.5-year project.
Wellmune WGP is a gluco polysaccharide that is clinically proven to safely prime key immune cells that help keep the body healthy. Derived from a proprietary strain of yeast, Wellmune WGP mobilizes neutrophils, which are the largest population of immune cells in the body and part of the body’s first line of defense.
“We are pleased that Wellmune WGP is part of this important scientific research project,” said Rich Mueller, Biothera president and CEO. “It will be complementary to our internal research program that is designed to expand understanding of our unique technology and its global immune health benefits.”
According to a FibeBiotics statement: “Research indicated that some specific polysaccharides, for example those from the cell wall of yeast or those that are present in various plant products, can activate the immune system starting from the intestine, even when no intruders are present. Various polysaccharides have been shown to activate macrophages, which can ‘digest’ pathogens and unwanted cells. An activated, warned or primed first layer of defence can help to improve the overall resistance of humans.”